PRCT Q4 2023 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$44M+83.3% YoY

Gross Profit

$21M48.8% margin

Operating Income

-$30M-67.8% margin

Net Income

-$28M-63.1% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

+24.2%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$34M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$405M

Total Liabilities

$124M

Stockholders' Equity

$281M

Cash & Equivalents

$257M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$24M	+83.3%
Gross Profit	$21M	$11M	+99.1%
Operating Income	-$30M	-$25M	-18.0%
Net Income	-$28M	-$28M	+2.4%

Geographic Segments

UNITED STATES

$68M92%

Outside the United States

$6M8%